George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 63.00
Bid: 61.00
Ask: 65.00
Change: 0.00 (0.00%)
Spread: 4.00 (6.557%)
Open: 63.00
High: 63.00
Low: 63.00
Prev. Close: 63.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Katoro's Blyvoor IPO on hold; Spectra bags new orders

Mon, 06th Dec 2021 21:32

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

---------

Schroder UK Public Private Trust PLC - formerly Woodford Patient Capital Trust, invests in both listed and private UK companies - BenevolentAI Ltd, which represented 5.2% of the company's net asset value at September 30, enters definitive agreement for a business combination with Amsterdam-listed investment company Odyssey Acquisition SA. BenevolentAI shareholders will receive Class A ordinary shares of Odyssey in exchange for their shares of BenevolentAI. As a result of the share exchange, BenevolentAI will become a wholly-owned subsidiary of Odyssey. "At the pro-forma market value, the implied valuation impact on the company's NAV is expected to be positive, however, the valuation of the company's holding will, following the listing on Euronext Amsterdam, be determined by reference to its share price," Schroder UK explains.

---------

Seraphim Space Investment Trust PLC - London-based investor in space technology - Makes USD25 million investment into Iceye Oy, a developer of synthetic aperture radar satellite imaging technology. Seraphim Space LP first invested in Iceye in 2017, prior to it launching its first satellite, and has participated in every subsequent Iceye funding round. Notes new investment will allow Iceye to "significantly expand its unique SAR satellite constellation".

---------

Pioneer Media Holdings Inc - Vancouver, Canada-based e-sports and mobile games investment company - Raises additional CAD400,000, around USD313,541, on a non-brokered private placement basis through the sale of 400,000 units at CAD1.00 per unit. Each unit consists of one share and one warrant, exercisable at CAD1.50 for 24 months. Brings total raised through this private placement to CAD1.5 million through the sale of 1.5 million units in aggregate. Company intends to use the funds raised to acquire additional investments in Web3, NFT-Gaming, eSport, mobile gaming, and related sectors. Also notes appointment of Julia Becker to its board of directors. Becker is the founder and president of Strike Communications Inc, a capital markets advisory firm specializing in technology, media and gaming.

---------

Spectra Systems Corp - Rhode Island-based authentication technology provider - Says newest customer using the company's optical materials in K-cups for Keurig brewers has already placed three orders totaling USD394,000 since September. The orders from the new customer are already 93% of the expected 2021 revenues from this product and 46% higher than total orders in 2020. Chief Executive Nabil Lawandy says: "Based on this order pattern, we expect that this new customer, along with the existing customer, will result in over USD1 million of high margin revenue in 2022."

---------

Induction Healthcare Group PLC - London-based hospital IT systems provider - Says its remote consultation service, Induction Attend Anywhere, launches new healthcare function. The platform, which has been rolled out across the UK, now also supports clinical group consultations, where one-to-one consultations take place within a group setting of patients with similar clinical conditions. "Co-created with NHS providers, the Induction Attend Anywhere clinical group consultations function has been designed to virtually mirror standard clinical and patient workflow for optimum integration. A distinctive feature is that there is a single-entry link for each clinical group consultation Waiting Area, avoiding production of multi-patient links and helping to safeguard clinician and patient confidentiality," company explains.

---------

Open Orphan PLC - London-based pharmaceutical services company - Subsidiary hVIVO conducts Phase 2a randomised, double-blinded, placebo-controlled study for SAB Biotherapeutics' human challenge study testing SAB-176, its investigational therapeutic for the treatment of seasonal influenza. Company notes SAB-176 met its primary endpoint and based on partial data appears to have met a key secondary endpoint. "These encouraging results support proceeding to a Phase 2 clinical trial," company adds.

---------

NetScientific PLC - London-based life sciences and sustainability, technology investment and commercialisation firm - Portfolio company, PDS Biotechnology Corp, reopens recruitment in the National Cancer Institute-led Phase 2 clinical trial evaluating PDS0101, marketed as Versamune-HPV16 in combination with two investigational immune-modulating agents in advanced HPV cancers. "The suspension of recruitment was administrative in nature and was unrelated to any specific safety or efficacy concerns associated with the triple combination being studied. As a result, during the recruitment suspension, patients already enrolled in the study continued to receive scheduled treatment. The timing of clinical results from this trial is not expected to be affected by the pause in recruitment of new patients," company says.

---------

InnovaDerma PLC - London-based developer of beauty, personal care and life science products - Signs joint venture agreement wit Non-Executive Director Ward to "accelerate and develop" the Prolong brand. Company will retain a 45% ownership stake in the venture, with the remaining 55% being acquired by Ward for a value of GBP275,000. "The objective of the joint venture is to accelerate the marketing and sales of the Prolong medical device and enable the company to focus on its topical products. The company will not be required to invest in Prolong's development as part of the joint venture nor will there be operational use of executive management's time," company's says.

---------

Vesuvius PLC - London-based molten metal flow engineering firm - Completes USD57.1 million acquisition of the assets and substantially all of the liabilities of Universal Refractories Inc, a specialty refractory producer based in Pennsylvania, USA.

---------

Katoro Gold PLC - gold and nickel exploration and development company - Deal for Target Mine Consulting falls through as TMC fails to supply initial public offering documentation. Initial public offering of joint venture between pair, Blyvoor, now in jeopardy. "The company is at the moment considering its position and options in this matter and will update the market accordingly as soon as a decision has been taken on an appropriate course of action," company says.

---------

Chesterfield Resources PLC - London-based minerals company - Drills high-grade gold-silver intercepts in Cyprus and discovers significant mineralised system. Notes thick and locally high-grade gold intersections at Westline target at its Cyprus Troodos West project. Says recent drilling provides evidence of a significant gold-enriched mineralized system so far covering approximately 220 metres by 300 metres in area, and open on three sides. Highlights from drilling show 21.4 meters grading 1.75 grams per tonne gold, and within this a high-grade zone of 3.3 metres grading 6.55 grams per tonne gold and 90.35 grams per tonne silver.

---------

Adriatic Metals PLC - precious and base metals explorer and developer - Says exploration drilling northwest of the Rupice Mineral Resource continues to intercept additional high-grade mineralisation. Chief Executive Paul Cronin says: "The extensional drilling completed to date demonstrates that excellent exploration potential still remains at Rupice. While extending the known mineralised zone by 145 metres, BR-12-21 also shows a thickening of the massive sulphide mineralisation to the north. We plan for drilling to continue through winter, alongside the civil earth works underway for the Rupice Underground Mine surface infrastructure." Notes diamond drillhole BR-12-21, 145 metres northwest of the existing Rupice Mineral Resource, intercepted 24.7 metres at 514 grammes per tonne zinc from 295.1 metres

---------

Zenith Energy Ltd - Africa-focused production and development energy company - Enters supplementary loan agreement with Winance, a company registered in the Cayman Islands with a single-family office based in Dubai, for an additional EUR3 million. Loan has duration of eight months and does not attract interest. Confirms made a drawdown of EUR1 million. Possible future drawdowns will be solely at company's discretion.

---------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Apr 2024 11:06

NetScientific investee secures funding to develop product range

(Alliance News) - NetScientific PLC on Monday said its portfolio company ProAxsis Ltd secured GBP1.8 million in investment.

Read more
27 Mar 2024 18:47

TRADING UPDATES: Empire Metals targets key milestones in Australia

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Mar 2024 17:04

NetScientific "significantly" advances strategic goals

(Alliance News) - NetScientific PLC on Wednesday released a portfolio and strategy update.

Read more
23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
1 Dec 2023 11:59

IN BRIEF: NetScientific investee DeepTech Recycling bags GBP1 million

NetScientific PLC - technology and life sciences investor - Portfolio company DeepTech Recycling Ltd closes GBP1 million fundraising. DeepTech, in which NetScientific holds a 30% stake, is a company focused on chemical recycling of plastic waste. Last December, it bought the assets of Recycling Technologies Ltd out of administration. The fundraise is carried out via an advance share subscription agreement and is the first closing of a target investment programme of around GBP3 million, with further investment anticipated within the next six months.

Read more
9 Nov 2023 19:41

IN BRIEF: NetScientific's portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor -

Read more
6 Nov 2023 12:00

IN BRIEF: NetScientific says Ventive on fire with new investment

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor - Says portfolio company Ventive, a London-based designer and manufacturer of heating and ventillation solutions, has successfuly closed a new investment of around GBP900,000. Funding included GBP316,000 from existing shareholders and the conversion of two existing convertible loans valued at about GBP600,000. Investment is part of Ventive's proposed GBP1 million to GBP1.5 million programme, with further investments expected by April 30. NetScientific now holds an 11% total equity stake in Ventive, with a post-investment fair value of GBP893,000 - up from GBP52,000 at December 31.

Read more
23 Oct 2023 21:10

NetScientific investee claims promising results in biomarker study

(Alliance News) - NetScientific PLC on Monday said its investee PDS Biotechnology Corp was "encouraged" by study data for its PDS0101 combined with Merck & Co Inc's drug Keytruda.

Read more
3 Oct 2023 17:12

IN BRIEF: NetScientific portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investment company - Reports that its portfolio company, PDS Biotechnology Corp, has announced updated interim data from the Versatile-002 phase two clinical trial evaluating PDS0101 in combination with Merck & Co Inc's Keytruda in patients with unresectable, recurrent, or metastatic HPV16-positive head and neck squamous cell carcinoma.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
13 Sep 2023 21:32

NetScientific's Q-Bot completes GBP3.5 million investment programme

(Alliance News) - NetScientific PLC on Wednesday said that its portfolio company, Q-Bot, has successfully closed a GBP3.5 million investment programme.

Read more
14 Aug 2023 19:49

IN BRIEF: NetScientific's PDS suffers wider loss as R&D costs mount

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Portfolio company PDS Biotechnology Corp reports results for the quarter to June 30. Net loss was USD11.5 million, widened from USD5.8 million the year before. Higher loss primarily due to costs incurred in connection with research and development programmes, which more than doubled to USD8.0 million from USD3.8 million. Loss per share of USD0.37 compared to USD0.20 before. Further, PDS reports the successful submission of final clinical protocol and supporting information to the US Food & Drug Administration to initiate phase 3 Versatile-003 trial in the fourth quarter. Adds biomarker data from Versatile-002 will be presented at the European Society for Medical Oncology Congress.

Read more
30 Jun 2023 14:07

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Jun 2023 14:11

TRADING UPDATES: tinyBuild bemoans disappointing interim performance

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2023 17:15

IN BRIEF: NetScientific investee Vortex nabs six-figure investment

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Announces completion of new GBP3.2 million investment round in portfolio company Vortex Biotech Holdings Ltd, led by EMV Capital. NetScientific converted its GBP400,000 loan into equity alongside new Vortex investors. NetScientific now has a 24.98% total equity holding in Vortex. This equates to a post-investment fair value of GBP2.8 million, quadruple the GBP700,000 value reported at December 31.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.